Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease

Experimental Neurology

Volumn 142, Issue 1, 1996, Pages 80-88

  Chandrasekaran, Krish ^a   Hatanpää, Kimmo ^a   Brady, Daniel R ^a   Rapoport, Stanley I ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ALZHEIMER DISEASE; ENERGY METABOLISM; GLUCOSE UTILIZATION; HUMAN; MITOCHONDRION; MONKEY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW;

EID: 0030296713     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0180     Document Type: Article

References (103)

1. 1. ALONSO, A. C., T. ZAIDI, I. GRUNDKE-IQBAL, AND K. IQBAL. 1994. Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc. Natl. Acad. Sci. USA 91: 5562-5566.
2. 2. AMES, B. N., M. K. SHIGENAGA, AND T. M. HAGEN. 1995. Mitochondrial decay in aging. Biochim. Biophys. Acta 1271: 165-170.
3. 3. ATTARDI, G., A. CHOMYN, M. P. KING, B. KRUSE, P. L. POLOSA, AND N. N. MURDTER. 1989. Biogenesis and assembly of the mitochondrial respiratory chain: Structural, genetic and pathological aspects. Biochem. Soc. Trans. 18: 509-513.
4. 4. ATTARDI, G., AND G. SCHATZ. 1988. Biogenesis of mitochondria. Annu. Rev. Cell Biol. 4: 289-333.
5. 5. BLASS, J. P., AND G. E. GIBSON. 1991. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Rev. Neurol. (Paris) 147: 513-525.
6. 6. BOADO, R. J., AND W. M. PARDRIDGE. 1993. Glucose deprivation causes posttranscriptional enhancement of brain capillary endothelial glucose transporter gene expression via GLUT1 mRNA stabilization. J. Neurochem. 60: 2290-2296.
7. 7. BOADO, R. J., L. WANG, AND W. M. PARDRIDGE. 1994. Enhanced expression of the blood-brain barrier GLUT1 glucose transporter gene by brain-derived factors. Mol. Brain Res. 22: 259-267.
8. 8. BODENTEICH, A., L. G. MITCHELL, AND C. R. MERRIL. 1991. A lifetime of retinal light exposure does not appear to increase mitochondrial mutations. Gene 108: 305-310.
9. 9. BRODERSON, S. H., D. L. PATTON, AND W. L. STAHL. 1978. Fine structural localization of potassium-stimulated p-nitrophenylphosphatase activity in dendrites of the cerebral cortex. J. Cell Biol. 77: R13-R17.
10. 10. CAMERON, H. A., C. K. KALISZEWSKI, AND C. A. GREER. 1991. Organization of mitochondria in olfactory bulb granule cell dendritic spines. Synapse 8: 107-118.
11. 11. CARLSON, M. D., J. B. PENNEY, JR., AND A. B. YOUNG. 1993. NMDA, AMPA, and benzodiazepine binding site changes in Alzheimer's disease visual cortex. Neurobiol. Aging 14: 343-352.
12. 12. CHANDRASEKARAN, K., T. GIORDANO, D. R. BRADY, J. STOLL, K. HATANPÄÄ, L. S. MARTIN, AND S. I. RAPOPORT. 1994. Impairment in gene expression of oxidative metabolism in vulnerable brain regions in Alzheimer disease. Neurobiol. Aging 15: S125.
13. 13. CHANDRASEKARAN, K., T. GIORDANO, D. R. BRADY, J. STOLL, L. J. MARTIN, AND S. I. RAPOPORT. 1994. Impairment of mitochondrial cytochrome oxidase gene expression in Alzheimer disease. Mol. Brain Res. 24: 336-340.
14. 14. CHANDRASEKARAN, K., K. HATANPÄÄ, S. I. RAPOPORT, AND D. R. BRADY. In press. Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex of Alzheimer disease. Mol. Brain Res.
15. 15. CHANDRASEKARAN, K., J. STOLL, D. R. BRADY, AND S. I. RAPOPORT. 1992. Distribution of cytochrome oxidase (COX) activity and mRNA in monkey and human brain. COX mRNA distribution correlates with neurons vulnerable to Alzheimer pathology. Soc. Neurosci. Abstr. 18: 557.
16. 16. CHANDRASEKARAN, K., J. STOLL, D. R. BRADY, AND S. I. RAPOPORT. 1992. Localization of cytochrome oxidase (COX) activity and COX mRNA in the hippocampus and entorhinal cortex in the monkey brain: Correlation with specific neuronal pathways. Brain Res. 579: 333-336.
17. 17. CHANDRASEKARAN, K., J. STOLL, S. I. RAPOPORT, AND D. R. BRADY. 1993. Localization of cytochrome oxidase (COX) activity and COX mRNA in the perirhinal and superior temporal sulci of the monkey brain. Brain Res. 606: 213-219.
18. 18. CHAUHAN, N. B., J. M. LEE, AND G. J. SIEGEL. 1996. Declines in Na,K-ATPase α3-mRNA in the superior frontal cortex of Alzheimer's disease brain. J. Neurochem. 66(Suppl. 1): S9.
19. 19. CLELAND, W. W. 1967. Enzyme kinetics. Annu. Rev. Biochem. 36: 77-112.
20. 20. CORRAL-DEBRINSKI, M., T. HORTON, M. T. LOTT, J. M. SHOFFNER, A. C. MCEE, M. F. BEAL, B. H. GARHAM, AND D. C. WALLACE. 1994. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 23: 471-476.
21. 21. CORRAL-DEBRINSKI, M., G. STEPIEN, J. M. SHOFFNER, M. T. LOTT, K. KANTER, AND D. C. WALLACE. 1991. Hypoxemia is associated with mitochondrial DNA damage and gene induction. Implications for cardiac disease. J. Am. Med. Assoc. 266: 1812-1816.
22. 22. DAVIES, C. A., D. M. A. MANN, P. Q. SUMPTER, AND P. O. YATES. 1987. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J. Neurol. Sci. 78: 151-164.
23. 23. DECARLI, C. S., J. R. ATACK, M. J. BALL, J. A. KAYE, C. L. GRADY, P. FEWSTER, K. D. PETTIGREW, S. I. RAPOPORT, AND M. B. SCHAPIRO. 1992. Post-mortem regional neurofibrillary tangle densities but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer's disease patients. Neurodegeneration 1: 113-121.
24. 24. DEKOSKY, S. T., AND S. W. SCHEFF. 1990. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann. Neurol. 27: 457-464.
25. 25. DIETRICH, W. D., D. DURHAM, O. H. LOWRY, AND T. A. WOOLSEY. 1982. "Increased" sensory stimulation leads to changes in energy-related enzymes in the brain. J. Neurosci. 2: 1608-1613.
26. 26. ERECINSKA, M., AND I. A. SILVER. 1989. ATP and brain function. J. Cereb. Blood Flow Metab. 9: 2-19.
27. 27. FUKUYAMA, R., K. HATANPÄÄ, S. I. RAPOPORT, AND K. CHANDRASEKARAN. 1996. Gene expression of ND4, a subunit of complex i of oxidative phosphorylation in mitochondria, is decreased in temporal cortex of brains of Alzheimer's disease patients. Brain Res. 713: 290-293.
28. 28. GADALETA, M. N., V. PETRUZZELLA, M. RENIS, F. FRACASSO, AND P. CANTATORE. 1990. Reduced transcription of mitochondrial DNA in the senescent rat. Tissue dependence and effect of L-carnitine. Eur. J. Biochem. 187: 501-506.
29. 29. GELFAND, R., AND G. ATTARDI. 1981. Synthesis and turnover of mitochondrial ribonucleic acid in HeLa cells: The mature ribosomal and messenger ribonucleic acid species are metabolically unstable. Mol. Cell. Biol. 1: 497-511.
30. 30. GOTO, Y., I. NONAKA, AND S. HORAI. 1990. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 248: 651-653.
31. 31. GRADY, C. L., J. V. HAXBY, B. HORWITZ, J. GILLETTE, J. A. SALERNO, A. GONZALEZ-AVILES, L. E. UNGERLEIDER, R. E. CARSON, P. HERSCOVITCH, M. B. SCHAPIRO, AND S. I. RAPOPORT. 1993. Activation of cerebral blood flow during a visuoperceptual task in patients with Alzheimer-type dementia. Neurobiol. Aging 14: 35-44.
32. 3H]glutamate binding. J. Neurochem. 48: 543-551.
33. 33. HARIK, S. I., M. J. MITCHELL, AND R. N. KALARIA. 1989. Ouabain binding in the human brain. Effects of Alzheimer's disease and aging. Arch. Neurol. 46: 951-954.
34. 34. HARMAN, D. 1992. Free radical theory of aging. Mutat. Res. 275: 257-266.
35. 35. HARRIS, M. E., K. HENSLEY, D. A. BUTTERFIELD, R. A. LEEDLE, AND J. M. CARNEY. 1995. Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons. Exp. Neurol. 131: 193-202.
36. 36. HATANPÄÄ, K., D. R. BRADY, J. STOLL, S. I. RAPOPORT, AND K. CHANDRASEKARAN. 1994. Localization of the deficit in cytochrome oxidase (COX) activity and COX subunit mRNA within the cerebral cortex in Alzheimer's disease. Soc. Neurosci. Abstr. 20: 1253.
37. 37. HATANPÄÄ, K., D. R. BRADY, J. STOLL, S. I. RAPOPORT, AND K. CHANDRASEKARAN. Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann. Neurol., in press.
38. 38. HAYAKAWA, M., T. OZAWA, S. SUGIYAMA, M. TANAKA, AND T. OZAWA. 1991. Massive conversion of guanosine to 8-hydroxyguanosine in mouse liver mitochondrial DNA by administration of azidothymidine. Biochem. Biophys. Res. Commun. 176: 87-93.
39. 39. HAYASHI, J. I., S. OHTA, Y. KAGAWA, H. KONDO, H. KANEDA, H. YONEKAWA, D. TARAI, AND S. MIYABAYASHI. 1994. Nuclear but not mitochondrial genome involvement in human age-related mitochondrial dysfunction. J. Biol. Chem. 269: 6878-6883.
40. 40. HEDDI, A., P. LESTIENNE, D. C. WALLACE, AND G. STEPIEN. 1993. Mitochondrial DNA expression in mitochondrial myopathies and coordinated expression of nuclear genes involved in ATP production. J. Biol. Chem. 268: 12156-12163.
41. +-ATPase. Neurosci. Lett. 138: 188-192.
42. 42. HEVNER, R. F., S. LIU, AND M. T. WONG-RILEY. 1995. A metabolic map of cytochrome oxidase in the rat brain: Histochemical, densitometric and biochemical studies. Neuroscience 65: 313-342.
43. 43. HEVNER, R. F., AND M. T. T. WONG-RILEY. 1991. Neuronal expression of nuclear and mitochondrial genes for cytochrome oxidase (CO) subunits analyzed by in situ hybridization: Comparison with CO activity and protein. J. Neurosci. 11: 1942-1958.
44. 44. HEVNER, R. F., AND M. T. T. WONG-RILEY. 1993. Mitochondrial and nuclear gene expression for cytochrome oxidase subunits are disproportionately regulated by functional activity in neurons. J. Neurosci. 13: 1805-1819.
45. 45. HORTON, J. C., AND D. H. HUBEL. 1981. Regular patchy distribution of cytochrome oxidase staining in primary visual cortex of macaque monkey. Nature (London) 292: 762-764.
46. 46. HUTCHIN, T., AND G. CORTOPASSI. 1995. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc. Natl. Acad. Sci. USA 92: 6892-6895.
47. 47. IKEBE, S., M. TANAKA, K. OHNO, W. SATO, K. HATTORI, T. KONDO, Y. MIZUNO, AND T. OZAWA. 1990. Increase of deleted mitochondrial DNA in the striatum of Parkinson's disease and senescence. Biochem. Biophys. Res. Commun. 179: 1044-1048.
48. 48. KAGAWA, Y., AND S. OHTA. 1990. Regulation of mitochondrial ATP synthesis in mammalian cells by transcriptional control. Int. J. Biochem. 22: 219-229.
49. 49. KALARIA, R. N., AND S. I. HARIK. 1989. Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J. Neurochem. 53: 1083-1088.
50. 50. KISH, S. J., C. BERGERON, A. RAJPUT, S. DOZIC, F. MASTROGIACOMO, L.-J. CHANG, J. M. WILSON, L. M. DISTEFANO, AND J. N. NOBREGA. 1992. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59: 776-779.
51. 51. KUMAGAI, A. K., Y. S. KANG, R. J. BOADO, AND W. M. PARDRIDGE. 1995. Upregulation of blood-brain barrier GLUT1 transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes 44: 1399-1404.
52. 52. LEHNINGER, A. L., D. L. NELSON, AND M. M. Cox. 1993. Principles of Biochemistry, 2nd ed., pp. 1-1013. Worth Press, New York.
53. 53. LEWIS, D. A., M. J. CAMPBELL, R. D. TERRY, AND J. H. MORRISON. 1987. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: A quantitative study of visual and auditory cortices. J. Neurosci. 7: 1799-1808.
54. 54. LINNANE, A. W., S. MARZUKI, T. OZAWA, AND M. TANAKA. 1989. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet 1: 642-645.
55. 55. LIU, S., AND M. WONG-RiLEY. 1994. Nuclear-encoded mitochondrial precursor protein: Intramitochondrial delivery to dendrites and axon terminals of neurons and regulation of neuronal activity. J. Neurosci. 14: 5338-5351.
56. 56. LOWRY, O. H. 1975. Energy metabolism in brain and its control. Pages 48-64 in D. H. Ingvar and N. A. Lassen, Eds., Brain Work, Alfred Benzon Symposium VIII. Academic Press, New York.
57. 57. LOWRY, O. H., N. ROBERTS, K. Y. LEINER, M.-L. Wu, A. L. FARR, AND W. R. ALBERS. 1954. The quantitative histochemistry of the brain. J. Biol. Chem. 207: 39-49.
58. 2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228: 1115-1117.
59. 59. MASLIAH, E., R. D. TERRY, M. ALFORD, R. DETERESA, AND L. A. HANSEN. 1991. Cortical and subcortical patterns of synaptophysinlike immunoreactivity in Alzheimer's disease. Am. J. Pathol. 138: 235-246.
60. 60. MCGEER, P. L., H. KAMO, R. HARROP, E. G. MCGEER, W. R. W. MARTIN, B. D. PATE, AND D. K. B. LI. 1986. Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease. Neurology 36: 1569-1574.
61. 61. MECOCCI, P., U. MACGARVEY, AND M. F. BEAL. 1994. Oxidative damage to mitochondria DNA is increased in Alzheimer disease. Ann. Neurol. 36: 747-751.
62. 62. MENTIS, M. J., B. HORWITZ, C. L. GRADY, G. E. ALEXANDER, J. W. VANMETER, J. M. MAISOG, P. PIETRINI, M. B. SCHAPIRO, AND S. I. RAPOPORT. 1996. Visual cortical dysfunction in Alzheimer's disease evaluated with a temporally graded "stress test" during PET. Am. J. Psychiatry 153: 32-10.
63. 63. MUTISYA, E. M., A. C. BOWLING, AND M. F. BEAL. 1994. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63: 2179-2184.
64. 64. PARKER, W. D., JR., C. M. FILLEY, AND J. K. PARKS. 1990. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40: 1302-1303.
65. 65. PARKER, W. D., JR., N. J. MAHR, C. M. FILLEY, J. K. PARKS, D. HUGHES, D. A. YOUNG, AND C. M. CULLUM. 1994. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 44: 1086-1090.
66. 66. PARKER, W. D., JR., J. PARKS, C. M. FILLEY, AND B. K. KLEINSCHMIDT-DEMASTERS. 1994. Electron transport chain defects in Alzheimer's disease brain. Neurology 44: 1090-1096.
67. 67. PARSHAD, R., K. K. SANFORD, F. M. PRICE, L. K. MELNICK, L. E. NEE, M. B. SCHAPIRO, R. E. TARONE, AND J. H. ROBBINS. 1996. Fluorescent light-induced chromatid breaks distinguish Alzheimer disease cells from normal cells in tissue culture. Proc. Natl. Acad. Sci. USA 93: 5146-5150.
68. 68. PETTEGREW, J. W., W. E. KLUNK, K. PANCHALINGAM, J. N. KANFER, AND R. J. MCCLURE. 1995. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease. Neurobiol. Aging 16: 1-4.
69. 69. PIETRINI, P., M. L. FUREY, A. DANI, U. FREO, M. J. MENTIS, G. E. ALEXANDER, AND S. I. RAPOPORT. 1996. Functional response to audiovisual stimulation in Alzheimer patients: Potential for therapeutic interventions. Abstr. Soc. Neurosci. 22, 1176.
70. 70. RAPOPORT, S. I. 1970. The sodium-potassium exchange pump: Relation of metabolism to electrical properties of the cell. I. Theory. Biophys. J. 10: 246-259.
71. 71. RAPOPORT, S. I. 1976. Blood-Brain Barrier in Physiology and Medicine, pp. 1-316. Raven Press, New York.
72. 72. RAPOPORT, S. I. 1991. Positron emission tomography in Alzheimer's disease in relation to disease pathogenesis: A critical review. Cerebrovasc. Brain Metab. Rev. 3: 297-335.
73. 73. RAPOPORT, S. I., AND C. L. GRADY. 1993. Parametric in vivo brain imaging during activation to examine pathological mechanisms of functional failure in Alzheimer disease. Int. J. Neurosci. 70: 39-56.
74. 74. RAPOPORT, S. I., B. HORWITZ, C. L. GRADY, J. V. HAXBY, AND M. B. SCHAPIRO. 1989. Alzheimer's disease, a disease of the association neocortices and connected regions: Metabolic, cognitive and pathologic correlations. Pages 115-136 in H. J. Altman and B. Altman, Eds., Alzheimer's and Parkinson's diseases. Recent Advances in Research and Clinical Management. Plenum Press, New York.
75. 75. SANO, M., K. BELL, L. COTE, G. DOONEIEF, A. LAWTON, L. LEGLER, K. MARDER, A. NAINI, Y. STERN, AND R. MAYEUX. 1992. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease. Arch. Neurol. 49: 1137-1141.
76. 76. SCARPULLA, R. C. 1996. Nuclear respiratory factors and the pathways of nuclear-mitochondrial interaction. Trends Cardiovasc. Med. 6: 39-15.
77. 77. SCHAGGER, H., AND T. G. OHM. 1995. Human diseases with defects in oxidative phosphorylation. 2. F1F0 ATP-synthase defects in Alzheimer disease revealed by blue native polyacrylamide gel electrophoresis. Eur. J. Biochem. 227: 916-921.
78. 78. SCHEFF, S. W., S. T. DEKOSKY, AND D. A. PRICE. 1990. Quantitative assessment of cortical synaptic density in Alzheimer's disease. Neurobiol. Aging 11: 29-37.
79. 79. SHADEL, G. S., AND D. A. CLAYTON. 1993. Mitochondrial transcription initiation. Variation and conservation. J. Biol. Chem. 268: 16083-16086.
80. 80. SHEETZ, M. P., E. R. STEUER, AND T. A. SCHROER. 1989. The mechanism and regulation of fast axonal transport. Trends Neurosci. 12: 474-178.
81. 81. SHOFFNER, J. B., M. D. BROWN, A. TORRONI, M. T. LOTT, M. F. CABELL, S. S. MIRRA, M. F. BEAL, C. C. YANG, M. GEARING, R. SALVO, R. L. WATTS, J. L. JUNCOS, L. A. HANSEN, B. J. CRAIN, M. FAYAD, C. L. RECKORD, AND D. C. WALLACE. 1993. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17: 171-184.
82. 82. SHOFFNER, J. B., M. T. LOTT, A. M. LEZZA, P. SEIBEL, S. W. BALLINGER, AND D. C. WALLACE. 1990. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 61: 931-937.
83. 83. SIESJÖ, B. K. 1978. Brain Energy Metabolism, pp. 1-607. Wiley, Chichester.
84. 84. SIMONIAN, N. A., AND B. T. HYMAN. 1993. Functional alterations in Alzheimer's disease: Diminution of cytochrome oxidase in the hippocampal formation. J. Neuropathol. Exp. Neurol. 52: 580-585.
85. 85. SIMONIAN, N. A., AND B. T. HYMAN. 1994. Functional alterations in Alzheimer's disease: Selective loss of mitochondrial-encoded cytochrome oxidase mRNA in hippocampal formation. J. Neuropathol. Exp. Neurol. 53: 508-512.
86. 86. SIMPSON, I. A., K. R. CHUNDU, T. DAVIES-HILL, W. G. HONER, AND P. DAVIES. 1994. Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann. Neurol. 35: 546-551.
87. 87. SIMS, N. R., J. M. FINEGAN, J. P. BLASS, D. M. BOWEN, AND D. NEARY. 1987. Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res. 436: 30-38.
88. 88. SOKOLOFF, L. 1991. Relationship between functional activity and energy metabolism in the nervous system: Whether, where and why. Pages 52-67 in N. A. Lassen, D. H. Ingvar, M. E. Raichle, and L. Friberg, Eds., Brain Work and Mental Activity. Quantitative Studies with Radioactive Tracers. Alfred Benzon Symposium VIII. Munksgaard, Copenhagen.
89. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28: 897-916.
90. 90. SUZUKI, H., Y. HOSOKAWA, M. NISHIKIMI, AND T. OZAWA. 1991. Existence of common homologous elements in the transcriptional regulatory regions of human nuclear genes and mitochondrial gene for the oxidative phosphorylation system. J. Biol. Chem. 266: 2333-2338.
91. 91. VIRBASIUS, C. A., J. V. VIRBASIUS, AND R. C. SCARPULLA. 1993. NRF-1, an activator involved in nuclear-mitochondrial interactions, utilizes a new DNA-binding domain conserved in a family of developmental regulators. Genes Dev. 7: 2431-2445.
92. 92. VIRBASIUS, J. V., AND R. C. SCARPULLA. 1994. Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: A potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc. Natl. Acad. Sci. USA 91: 1309-1313.
93. 93. VIRBASIUS, J. V., C. A. VIRBASIUS, AND R. C. SCARPULLA. 1993. Identity of GABP with NRF-2, a multisubunit activator of cytochrome oxidase expression, reveals a cellular role for an ETS domain activator of viral promotors. Genes Dev. 4: 380-392.
94. 94. WALLACE, D. 1992. Mitochondrial genetics: A paradigm for aging and degenerative diseases. Science 256: 628-632.
95. +)-ATPase in cultured chick skeletal muscle. Modulation of expression by the demand for ion transport. J. Biol. Chem. 261: 9990-9999.
96. 96. WONG-RILEY, M. T. T. 1989. Cytochrome oxidase: An endogenous metabolic marker for neuronal activity. Trends Neurosci. 12: 94-101.
97. 97. WONG-RILEY, M. T. T., M. M. MERZENICH, AND P. A. LEAKE. 1978. Changes in endogenous enzymatic reactivity to DAB induced by neuronal inactivity. Brain Res. 141: 185-192.
98. 98. WONG-RILEY, M. T. T., S. M. WALSH, P. A. LEAKE-JONES, AND M. M. MERZENICH. 1981. Maintenance of neuronal activity by electrical stimulation of unilaterally deafened cats, demonstrable with cytochrome oxidase technique. Ann. Otol. Rhinol. Laryngol. 90(Suppl. 2): 30-32.
99. 99. WONG-RILEY, M. T. T., AND C. WELT. 1980. Histochemical changes in cytochrome oxidase of cortical barrels after vibrissal removal in neonatal and adult mice. Proc. Natl. Acad. Sci. USA 77: 2333-2337.
100. 100. WRAGG, M. A., C. J. TALBOT, J. C. MORRIS, C. L. LENDON, AND A. M. GOATE. 1995. No association found between Alzheimer's disease and a mitochondrial tRNA glutamine gene variant. Neurosci. Lett. 201: 107-110.
101. 101. YAMAMOTO, K., U. IKEDA, K. OKADA, T. SAITO, K. KAWAKAMI, AND K. SHIMADA. 1994. Sodium ion mediated regulation of Na/K-ATPase gene expression in vascular smooth muscle cells. Cardiovasc. Res. 28: 957-962.
102. 102. YAROWSKY, P., M. KADEKARO, AND L. SOKOLOFF. 1983. Frequency-dependent activation of glucose utilization in the superior cervical ganglion by electrical stimulation of cervical sympathetic trunk. Proc. Natl. Acad. Sci. USA 80: 4179-4183.
103. 103. YEN, T.-C., J.-H. Su, K.-L. KING, AND Y.-H. WEI. 1991. Ageing-associated 5 kb deletion in human liver mitochondrial DNA. Biochem. Biophys. Res. Commun. 178: 124-131.